Article
Rs2686344 and serum squamous cell carcinoma antigen could predict clinical efficacy of neoadjuvant chemotherapy for cervical cancer.
Current problems in cancer - 1 Dec 2021
Li Ting, Huang Huan, Hu Yi, Chen Hongwei, Li Rui, Lu Hao, Yan Lin, Chen Ying, Zhang Chun, Zhang Qinghua, Li Xiong
Abstract excerpt
OBJECTIVE: To evaluate the predictive value of a single nucleotide polymorphism (SNP) rs2686344 and squamous cell carcinoma antigen (SCCAg) levels in the clinical efficacy of neoadjuvant chemotherapy (NACT) for cervical cancer. METHODS: A total of 92 patients with stage IB2-IIIB carcinoma of the uterine cervix who received NACT treatment were enrolled. The relationship between the genotypes of SNP rs2686344 which...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
